Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage

Journal of Immunology

Volumn 183, Issue 9, 2009, Pages 6013-6020

  Sansonno, Domenico ^a   Tucci, Felicia Anna ^a   Ghebrehiwet, Berhane ^b   Lauletta, Gianfranco ^a   Peerschke, Ellinor I B ^c   Conteduca, Vincenza ^a   Russi, Sabino ^a   Gatti, Pietro ^a   Sansonno, Loredana ^a   Dammacco, Franco ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b STONY BROOK UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; CRYOGLOBULIN; MESSENGER RNA; PEGINTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; CYTOKINE RELEASE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; SKIN BIOPSY; UPREGULATION;

COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, COMPLEMENT; UP-REGULATION; VASCULITIS; VIRAL CORE PROTEINS;

EID: 77954163239     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902038     Document Type: Article

References (52)

1. Dammacco, F., D. Sansonno, C. Piccoli, F. A. Tucci, and V. Racanelli. 2001. The cryoglobulins: an overview. Eur J. Clin. Invest. 31: 628-638.
2. Gumber, S. C., and S. Chopra. 1995. Hepatitis C: a multifaceted disease: review of extrahepatic manifestations. Ann. Intern. Med. 123: 615-620.
3. Dammacco, F., D. Sansonno, C. Piccoli, V. Racanelli, F. P. D'Amore, and G. Lauletta. 2000. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin. Liver Dis. 20: 143-157. (Pubitemid 30618713)
4. Miescher, P. A., Y. P. Huang, and S. Izui. 1995. Type II cryoglobulinemia. Semin. Hematol. 32: 80-85.
5. Sansonno, D., A. Carbone, V. De Re, and F. Dammacco. 2007. Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46: 572-578.
6. Saadoun, D., M. Rosenzwajg, D. Landau, J. C. Piette, D. Klatzmann, and P. Cacoub. 2008. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis. Blood 111: 5334-5341.
7. Sansonno, D., G. Lauletta, L. Nisi, P. Gatti, F. Pesola, N. Pansini, and F. Dammacco. 2003. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin. Exp. Immunol. 133: 275-282.
8. Aoyagi, K., C. Ohue, K. Iida, T. Kimura, E. Tanaka, K. Kiyosawa, and S. Yagi. 1999. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J. Clin. Microbiol. 37: 1802-1808. (Pubitemid 29235226)
9. Maillard, P., K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic, and A. Budkowska. 2001. Non-enveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J. Virol. 75: 8240-8250.
10. Sabile, A., G. Perlemuter, F. Bono, K. Kohara, F. Demaugre, M. Kohara, Y. Matsuura, T. Miyamura, C. Brechot, and G. Barba. 1999. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 30: 1064-1076.
11. Bouvier-Alias, M., K. Patel, H. Dahari, S. Beaucourt, P. Larderie, L. Blatt, C. Hezode, G. Picchio, D. Dhumeaux, A. U. Neumann, J. G. McHutchison, and J. M. Pawlotsky. 2002. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 36: 211-218.
12. Kurtz, J. B., E. Boxall, N. Qusir, J. Shirley, D. Coleman, and C. Chandler. 2001. The diagnostic significance of an assay for "total" hepatitis C core antigen. J. Virol. Methods 96: 127-132.
13. Gorevic, P. D., and B. Frangione. 1991. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin. Hematol. 28: 79-94.
14. Lindahl, G., U. Sjobring, and E. Johnsson. 2000. Human complement regulators: a major target for pathogenic microorganisms. Curr. Opin. Immunol. 12: 44-51.
15. Kittlesen, D. J., K. A. Chianese-Bullock, Z. Q. Yao, T. J. Braciale, and Y. S. Hahn. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106: 1239-1249.
16. Yao, Z. Q., D. T. Nguyen, A. I. Hiotellis, and Y. S. Hahn. 2001. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 167: 5264-5272.
17. Yao, Z. Q., S. Ray, A. Eisen-Vandervelde, S. Waggoner, and Y. S. Hahn. 2001. Hepatitis C virus: immunosuppression by complement regulatory pathway. Viral Immunol. 14: 277-295. (Pubitemid 34309058)
18. Yao, Z. Q., D. Prayther, C. Trabue, Z. P. Dong, and J. Moorman. 2008. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein. Immunology 125: 197-207.
19. Ghebrehiwet, B., B. L. Lim, R. Kumar, X. Feng, and E. I. Peerschke. 2001. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol. Rev. 180: 65-77.
20. Eggleton, P., B. Ghebrehiwet, K. N. Sastry, J. P. Coburn, K. S. Zaner, K. B. Reid, and A. I. Tauber. 1995. Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils: subcellular localization and binding properties in comparison with the cC1q-R. J. Clin. Invest. 95: 1569-1578.
21. Lim, B. L., K. B. Reid, B. Ghebrehiwet, E. I. Peerschke, L. A. Leigh, and K. T. Preissner. 1996. The binding protein for globular heads of complement C1q, gC1qR: functional expression and characterization as a novel vitronectin binding factor. J. Biol. Chem. 271: 26739-26744.
22. Sansonno, D., V. Cornacchiulo, A. R. Iacobelli, R. Di Stefano, M. Lospalluti, and F. Dammacco. 1995. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 21: 305-312.
23. Sansonno, D., L. Gesualdo, C. Manno, F. P. Schena, and F. Dammacco. 1997. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 25: 1237-1244.
24. Joseph, K., B. Ghebrehiwet, E. I. Peerschke, K. B. Reid, and A. P. Kaplan. 1996. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc. Natl. Acad. Sci. USA 93: 8552-8557.
25. Paul, D. B., M. C. Kuhns, A. L. McNamara, J. C. Pottage, Jr., and G. T. Spear. 1995. Short-term stability of HIV provirus levels in the peripheral blood of HIV-infected individuals. J. Med. Virol. 47: 292-297.
26. Yu, L., Z. Zhang, P. M. Loewenstein, K. Desai, Q. Tang, D. Mao, J. S. Symington, and M. Green. 1995. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain. J. Virol. 69: 3007-3016.
27. Simos, G., and S. D. Georgatos. 1994. The lamin B receptor-associated protein p34 shares sequence homology and antigenic determinants with the splicing factor 2-associated protein p32. FEBS Lett. 346: 225-228.
28. Krainer, A. R., A. Mayeda, D. Kozak, and G. Binns. 1991. Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and drosophila splicing regulators. Cell 66: 383-394.
29. Seytter, T., F. Lottspeich, W. Neupert, and E. Schwarz. 1998. Mam33p, an oligomeric, acidic protein in the mitochondrial matrix of Saccharomyces cerevisiae is related to the human complement receptor gC1q-R. Yeast 14: 303-310.
30. Sunayama, J., Y. Ando, N. Itoh, A. Tomiyama, K. Sakurada, A. Sugiyama, D. Kang, F. Tashiro, Y. Gotoh, Y. Kuchino, and C. Kitanaka. 2004. Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32. Cell Death Differ. 11: 771-781.
31. Matthews, D. A., and W. C. Russell. 1998. Adenovirus core protein V interacts with p32-a protein which is associated with both the mitochondria and the nucleus. J. Gen. Virol. 79: 1677-1685.
32. Luo, Y., H. Yu, and B. M. Peterlin. 1994. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68: 3850-3856. (Pubitemid 24177410)
33. Tange, T. O., T. H. Jensen, and J. Kjems. 1996. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32. J. Biol. Chem. 271: 10066-10072.
34. Peterson, K. L., W. Zhang, P. D. Lu, S. A. Keilbaugh, E. I. Peerschke, and B. Ghebrehiwet. 1997. The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization. Clin. Immunol. Immunopathol. 84: 17-26.
35. Feng, X., M. G. Tonnesen, E. I. Peerschke, and B. Ghebrehiwet. 2002. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J. Immunol. 168: 2441-2448. (Pubitemid 34171848)
36. Joseph, K., B. Ghebrehiwet, and A. P. Kaplan. 2001. Activation of the kinin-forming cascade on the surface of endothelial cells. Biol. Chem. 382: 71-75.
37. Ishak, K. G. 1994. Chronic hepatitis: morphology and nomenclature. Mod. Pathol. 7: 690-713.
38. Dammacco, F., D. Sansonno, J. H. Han, V. Shyamala, V. Cornacchiulo, A. R. Iacobelli, G. Lauletta, and R. Rizzi. 1994. Natural interferon-α versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 84: 3336-3343.
39. Ghebrehiwet, B., B. L. Lim, E. I. Peerschke, A. C. Willis, and K. B. Reid. 1994. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J. Exp. Med. 179: 1809-1821.
40. Crowle, A. J. 1980. Precipitin and microprecipitin reactions in fluid medium and in gels. In Manual of Clinical Immunology, 2nd ed. H. F. N. R. Rose, ed. American Society of Microbiology, Washington, DC. pp. 3-14.
41. Vegh, Z., E. C. Goyarts, K. Rozengarten, A. Mazumder, and B. Ghebrehiwet. 2003. Maturation-dependent expression of C1q binding proteins on the cell surface of human monocyte-derived dendritic cells. Int. Immunopharmacol. 3: 39-51. (Pubitemid 36106449)
42. Nilsson, K., and K. Mosbach. 1980. p-Toluenesulfonyl chloride as an activating agent of agarose for the preparation of immobilized affinity ligands and proteins. Eur. J. Biochem. 112: 397-402.
43. Sansonno, D., V. Cornacchiulo, V. Racanelli, and F. Dammacco. 1997. In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma. Cancer 80: 22-33.
44. Peerschke, E. I., and B. Ghebrehiwet. 1988. Identification and partial characterization of human platelet C1q binding sites. J. Immunol. 141: 3505-3511.
45. Jiang, J., Y. Zhang, A. R. Krainer, and R. M. Xu. 1999. Crystal structure of human p32, a doughnut-shaped acidic mitochondrial matrix protein. Proc. Natl. Acad. Sci. USA 96: 3572-3577.
46. Fujita, T., I. Gigli, and V. Nussenzweig. 1978. Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J. Exp. Med. 148: 1044-1051.
47. Okroj, M., D. Heinegard, R. Holmdahl, and A. M. Blom. 2007. Rheumatoid arthritis and the complement system. Ann. Med. 39: 517-530.
48. Nickeleit, V., and M. J. Mihatsch. 2003. Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol. Dial. Transplant. 18: 2232-2239.
49. Paidassi, H., P. Tacnet-Delorme, V. Garlatti, C. Darnault, B. Ghebrehiwet, C. Gaboriaud, G. J. Arlaud, and P. Frachet. 2008. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J. Immunol. 180: 2329-2338.
50. Guo, W. X., B. Ghebrehiwet, B. Weksler, K. Schweitzer, and E. I. Peerschke. 1999. Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines. J. Lab. Clin. Med. 133: 541-550.
51. Peerschke, E. I., W. Yin, and B. Ghebrehiwet. 2008. Platelet mediated complement activation. Adv. Exp. Med. Biol. 632: 81-91.
52. Peerschke, E. I., and B. Ghebrehiwet. 1998. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunobiology 199: 239-249.